| # | Drug | Count |
|---|---|---|
| 0 | ADALIMUMAB | 954 |
| 1 | GOLIMUMAB | 322 |
| 2 | GUSELKUMAB | 322 |
| 3 | PEGINTERFERON BETA-1A | 274 |
| 4 | EXENATIDE | 218 |
| 5 | PEGFILGRASTIM | 187 |
| 6 | METHOTREXATE SODIUM | 167 |
| 7 | METHOTREXATE | 164 |
| 8 | INTERFERON BETA-1A | 139 |
| 9 | USTEKINUMAB | 130 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | POTASSIUM CHLORIDE, SODIUM CHLORIDE, CALCIUM CHLORIDE, AND MAGNESIUM CHLORIDE | 1 | 0.0476 |
| 1 | GUSELKUMAB | 322 | 0.0261 |
| 2 | PEGINTERFERON BETA-1A | 274 | 0.0247 |
| 3 | BECLOMETHASONE DIPROPIONATE HFA | 35 | 0.0203 |
| 4 | BUDESONIDE, GLYCOPYRROLATE, AND FORMOTEROL FUMARATE | 5 | 0.0144 |
| 5 | PENTOBARBITAL SODIUM | 1 | 0.0093 |
| 6 | GLYCOPYRROLATE AND FORMOTEROL FUMARATE | 12 | 0.0088 |
| 7 | ORPHENADRINE CITRATE, ASPIRIN AND CAFFEINE | 1 | 0.0088 |
| 8 | CARBINOXAMINE MALEATE | 1 | 0.0071 |
| 9 | BREMELANOTIDE | 1 | 0.0066 |
| # | Drug class | Count |
|---|---|---|
| 0 | Interleukin-23 Antagonist [EPC] | 452 |
| 1 | Interferon beta [EPC] | 413 |
| 2 | Tumor Necrosis Factor Blocker [EPC] | 337 |
| 3 | Corticosteroid [EPC] | 246 |
| 4 | GLP-1 Receptor Agonist [EPC] | 224 |
| 5 | Leukocyte Growth Factor [EPC] | 187 |
| 6 | Nonsteroidal Anti-inflammatory Drug [EPC] | 182 |
| 7 | Folate Analog Metabolic Inhibitor [EPC] | 164 |
| 8 | Interleukin-12 Antagonist [EPC] | 130 |
| 9 | Vitamin B12 [EPC] | 116 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-23 Antagonist [EPC] | 452 | 0.0049 |
| 1 | Interferon beta [EPC] | 413 | 0.0021 |
| 2 | Interleukin-12 Antagonist [EPC] | 130 | 0.0019 |
| 3 | Prostacycline [EPC] | 17 | 0.0018 |
| 4 | Leukocyte Growth Factor [EPC] | 187 | 0.0017 |
| 5 | GLP-1 Receptor Agonist [EPC] | 224 | 0.0011 |
| 6 | Bile Acid Sequestrant [EPC] | 6 | 0.0007 |
| 7 | Interleukin-6 Receptor Antagonist [EPC] | 51 | 0.0006 |
| 8 | Vitamin D Analog [EPC] | 2 | 0.0005 |
| 9 | Folate Analog Metabolic Inhibitor [EPC] | 164 | 0.0005 |